A prospective , randomized study of 30 patients , randomized into Group I ( Warfarin ) and Group II ( AAS ) , underwent total cavopulmonary shunt with extracardiac conduit , between 2008 and 2011 , with follow-up by clinical visits to evaluate side effects and adhesion .